DOCSLIB.ORG

Inhibition of Cyclin Dl Expression and Phosphorylation of Retinoblastoma Protein by Phosmidosine, a Nucleotide Antibiotic1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Inhibition of Cyclin Dl Expression and Phosphorylation of Retinoblastoma Protein by Phosmidosine, a Nucleotide Antibiotic1 [CANCER RESEARCH 58. 704-710. February 15. I998| Inhibition of Cyclin Dl Expression and Phosphorylation of Retinoblastoma Protein by Phosmidosine, a Nucleotide Antibiotic1 Hideaki Kakeya, Rie Onose, Phillip C.-C. Liu,2 Chizuko Onozawa, Fuini«Matsumura, and Hiroyuki Osada3 Antibiotics Laboratory, The Insiliate of Physical ami Chemical Research (RIKEN), Saitama 35I-OI9N, Japan ¡H.K., R. O., C. O.. H. O.¡,and Department of Environmental Toxicology, and Institute of Toxicology and Environmental Health. University of California. Davis. California 95695 {P. C.-C. L., F. M.J ABSTRACT implicated in the phosphorylation of pRB. Ectopie expression of cyclin Dl induces phosphorylation of pRB and accelerates progres In this report, we studied the effect of phosmidosine, a proline-contain- sion through G, (14, 15). In addition, microinjection of either anti- ing nucleotide on the serum-induced cell cycle progression in human lung fihroblast YVI-38 cells. Phosmidosine suppressed S-phase entry and ar cyclin Dl antibodies or antisense plasmid prevents cells from entering rested cell cycle progression at the I., phase. In serum-stimulated cells, S phase (14, 16, 17). phosmidosine did not affect the activation of the mitogen-activated protein Thus, understanding the underlying biochemical processes on the kinase cascade. However, phosmidosine inhibited hyperphosphorylation pRB functions will advance our knowledge of cellular proliferation in of retinohlastoma (RB) protein by RB-kinases such as cyclin-dependent general and also will have implications for efficient cancer therapies. kinase 4 and cyclin-dependent kinase 2, probably as a result of the Compounds that arrest cells at a specific point in the cell cycle have inhibition of cyclin Dl expression. Furthermore, in tsFT210 cells, a tem proven to be extremely useful tools for unraveling cell cycle regula perature-sensitive <•</<•_'mutantisolated from the mouse mammary carci tory events and might be useful for cancer chemotherapy. noma cell line FM3A, phosmidosine, irreversibly inhibited the cell cycle Phosmidosine (Fig. 1) inhibited the cell cycle progression at G, progression at G, without affecting the (., to M transition. Phosmidosine with the flat morphological reversion activity in NRK cells trans acts at an earlier point in G, compared with mimosine or aphidicolin, formed by temperature-sensitive Rous sarcoma virus (18-20). Its well-known cell cycle blockers at the G,-S boundary. Taken together, phosmidosine arrested cells at a spirille point between the start point and mechanism of action, however, has remained elusive. In this report, restriction point in <;, and is a useful drug that may contribute to the we show that phosmidosine treatment of a mouse carcinoma cell line understanding of the regulatory mechanisms of G, progression. as well as a human normal cell line arrested cell cycle progression at G,. Concomitantly, phosphorylation of pRB and expression of cyclin Dl are blocked. These effects are irreversible because cells from INTRODUCTION which phosmidosine has been washed out remain arrested at G,. The RB4 gene is an antioncogene, the inactivation of which is often Because phosphorylation of pRB is essential for the G,-to-S transi tion, our experiments suggest that phosmidosine blocks cell growth by observed in various kinds of tumors including RBs and osteosarcomas ( 1). The RB gene product (pRB) is a nuclear protein of Mr 110,000- inhibiting hyperphosphorylation of pRB through the suppression of the cyclin Dl expression. 115.(XX)that forms complexes with the transforming protein encoded by DNA tumor virus, such as the adenovirus EIA protein, the SV40 (SV40) large T antigen, or the papilloma virus E7 protein. Recent MATERIALS AND METHODS genetic studies have revealed that complex formation between pRB and oncoproteins is closely linked with viral transforming activities Materials. Phosmidosine was isolated from Streptomyces durhameusis as (2-4). pRB also interacts specifically with several cellular proteins, described previously (18, 20). Human lung fibroblast WI-38 cells were ob including the transcription factor E2F and the proto-oncogene product tained from the RIKEN Cell Bank (Tsukuba, Japan). tsFT210 cells, a temper ature-sensitive cdc2 mutant isolated from the mouse mammary carcinoma cell Myc (5. 6). It is well known that pRB is phosphorylated in a cell cycle-dependent manner: hypophosphorylated in the G,,-G, phase and line FM3A, were a kind gift from Dr. F. Hanaoka (RIKEN; Ref. 21). MBP and hyperphosphorylated in the G,-to-S transition. Phosphorylation of histone HI were purchased from Sigma Chemical Co. (St. Louis, MO); and anti-cyclin Dl, anti-CDK2, and anti-CDK4 antibodies were purchased from pRB results in the dissociation of pRB and transcription factor, which Upstate Biotechnology (Lake Placid, NY). Anti-pRB antibody (PMG-245) was induces the S-phase entry (5, 7-9). obtained from PharMingen (San Diego, CA), and [7-32P]ATP was from 1CN Concomitant with these findings, pRB was shown to be phospho Biochemicals, Inc. (Costa Mesa, CA). rylated by CDKs in vitro and in vivo (10-13). CDK2/cyclin E com Cell Synchronization. WI-38 cells were grown at 37°Cin 5% CO2 in plex as well as CDK4/cyclin D phosphorylate pRB. Recent analysis of DMEM containing 10% FCS. Exponentially growing WI-38 cells were ar phosphorylation sites both in vitro and in vivo indicated that pRB is rested at G0 by incubation in DMEM medium supplemented with 0.2% PCS phosphorylated on more than 10 serine or threonine residues but is not for 3 days. Then these quiescent cells were stimulated by the addition of 10% phosphorylated on tyrosine residue. Cyclins of the D class (Dl, D2, FCS. tsFT2IO cells were maintained in RPMI 1640 with 10% PCS at the per and D3) complexed with CDK.4 or CDK6 are most prominently missive temperature of 32°Cand cultured at the nonpermissive temperature of 39°Cfor 17 h to synchronize them at the G2-M boundary. They were incubated Received 9/3/97; accepted 12/16/97. at 32°Cfor 4 h to induce their entry into G, (22). The costs of publication of this article were defrayed in part by the payment of page Flow Cytometric Analysis. Flow cytometric analysis was performed es charges. This article must therefore he hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. sentially as described by Noguchi and Browne (23). The harvested cells were 1This work was supported in part by a Special Grant for Promotion of Research stained with solution containing 50 fig/ml propidium iodide. 0.1% sodium (RIKEN). a Grant for Multibioprobes (RIKEN), and a Gram from the Ministry of citrate, and 0.2% NP40 and analyzed for DNA contents using a flow cytometer Education. Science. Sports and Culture. Japan. - Present address: Department of Biological Chemistry, University of Michigan Med (Profile II: Coulter Co., Hialeah, FL). [3H]Thymidine Incorporation. WI-38 cells were plated in 48-well plates ical School. Ann Arbor. Ml 48109-0606. ' To whom requests for reprints should be addressed, at The Institute of Physical and at 3 X IO4 cells/200 /il/well and cultured for 3 days. Cells were washed twice Chemical Research. RIKEN. Hirosawa 2-1. Wako-shi, Saitama .151-01, Japan. Phone: with serum-depleted DMEM and were incubated in DMEM containing 0.2% 81-48-467-9541; Fax: 81-48-462-4669; E-mail: [email protected]. 4 The abbreviations used are: RB. retinoblastoma; pRB. RB protein; CDK. cyclin- PCS at 37°Cfor 3 days. These quiescent cells were pretreated with various dependent kinase; MAP kinase, mitogen-activated protein kinase: MBP. myelin basic concentrations of phosmidosine for 15 min and stimulated with 10% FCS. protein: BrdUrd. 5-bromo-2'-deoxyuridine; CAK. CDK-activating kinase. After 18 h incubation in media with 10% FCS. the cells were labeled for 2 h 704 Downloaded from cancerres.aacrjournals.org on October 1, 2021. © 1998 American Association for Cancer Research. PHOSMIDOSINE EFFECTS ON CYCLIN Dl AND pRB NH2 RESULTS Phosmidosine Arrests WI-38 Cell Cycle Progression at G,. The cell cycle progression of human lung fibroblast WI-38 cells was monitored by flow cytometry. Exponentially growing WI-38 cells had two peaks: 2 C DNA (G0-G, phase) and 4 C DNA (G2-M phase). A saddle peak between 2 C and 4 C peak was S phase, which was confirmed by the incorporation of BrdUrd, a thymidine analogue, into replicating DNA (Fig. 2, A-a and B-a). Phosmidosine (10 /MM)appar ently decreased the saddle peak area between 2 C and 4 C and the incorporation of BrdUrd (Fig. 2, A-b and B-b). After washing out the phosmidosine and allowing the cells to recover for 24 h, the cell cycle profile did not change appreciably (Fig. 2, A-c and B-c) from cells that were not allowed to recover (Fig. 2, A-b and B-b). These data indicate that phosmidosine irreversibly blocks the progression of WI-38 cells in G,. This arrest was not due to toxicity of the drug, as determined Fig. l. Structure of phosmidosine. by trypan blue exclusion (data not shown). Because phosmidosine appeared to arrest cycling cells at G,, we examined its effect on S-phase entry by quiescent WI-38 cells. with 2 fiCi/ml ['HJthymidine (25 mCi/ml; Amersham International, Bucking [3H]Thymidine incorporation was detected 16 h after serum addi hamshire, England), washed twice with 5% trichloroacetic acid, and lysed with tion, peaked after 23 h, and then declined (data not shown). We l N NaOH. The radioactive content of the resulting trichloroacetic acid- pretreated quiescent WI-38 cells with several concentrations of insoluble fractions was measured with a liquid scintillation counter (TriCurve; phosmidosine for 15 min, stimulated the cells with serum, and Packard, Meriden, CT). added [3H]thymidine 18 h later.
Load more

Recommended publications
  • Cloning of a D-Type Cyclin from Murine Erythroleukemia Cells (CYL2 Cdna/Cell Cycle) HIROAKI KIYOKAWA*, XAVIER BUSQUETS, C
    Proc. Natl. Acad. Sci. USA Vol. 89, pp. 2444-2447, March 1992 Cell Biology Cloning of a D-type cyclin from murine erythroleukemia cells (CYL2 cDNA/cell cycle) HIROAKI KIYOKAWA*, XAVIER BUSQUETS, C. THOMAS POWELL, LANG NGo, RICHARD A. RIFKIND, AND PAUL A. MARKS DeWitt Wallace Research Laboratory, Memorial Sloan-Kettering Cancer Center and the Sloan-Kettering Division of the Graduate School of Medical Sciences, Cornell University, New York, NY 10021 Contributed by Paul A. Marks, December 13, 1991 ABSTRACT We report the complete coding sequence of a could be important in regulating G1 cell cycle progression, in cDNA, designated CYL2, derived from a murine erythroleu- governing S-phase commitment to differentiation, or in tu- kemia cell library. CYL2 is considered to encode a D-type morigenesis (27, 28). We now report the isolation and nucle- cyclin because (i) there is cross hybridization with CYL1 (a otide sequence of a D-type cyclin, designated CYL2,t from murine homolog of human cyclin D1) and the encoded protein murine erythroleukemia cells (MELCs). The observed fluc- has 64% amino acid sequence identity with CYL1 and (it) tuation in level ofCYL2 mRNA during the cell cycle suggests murine erythroleukemia cell-derived CYL2 contains an amino a role in commitment to the G1 to S phase transition. acid sequence identical to that previously reported for the C-terminal portion ofa partially sequenced CYL2. Transcripts MATERIALS AND METHODS of murine erythroleukemia cell CYL2 undergo alternative polyadenylylation like that of human cyclin Di. A major Cell Cultures. DS19/Sc9 MELCs, derived from 745A cells 6.5-kilobase CYL2 transcript changes its expression during the (29), were maintained in a-modified minimal essential me- cell cycle with a broad peak through G, and S phases and a dium supplemented with 10% (vol/vol) fetal calf serum.
    [Show full text]
  • MAPK3/1 (ERK1/2) and Myosin Light Chain Kinase in Mammalian Eggs
    BIOLOGY OF REPRODUCTION (2015) 92(6):146, 1–14 Published online before print 22 April 2015. DOI 10.1095/biolreprod.114.127027 MAPK3/1 (ERK1/2) and Myosin Light Chain Kinase in Mammalian Eggs Affect Myosin-II Function and Regulate the Metaphase II State in a Calcium- and Zinc-Dependent Manner1 Lauren A. McGinnis,3 Hyo J. Lee,3 Douglas N. Robinson,4 and Janice P. Evans2,3 3Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 4Department of Cell Biology, School of Medicine, Johns Hopkins University, Baltimore, Maryland ABSTRACT activation. Inability to exit from metaphase II arrest upon fertilization is associated with female infertility [2, 3]. Proper Vertebrate eggs are arrested at metaphase of meiosis II, a state maintenance of metaphase II arrest in unfertilized eggs is also classically known as cytostatic factor arrest. Maintenance of this crucial for reproductive success, with failure of eggs to arrest until the time of fertilization and then fertilization- maintain metaphase II arrest being associated with reduced induced exit from metaphase II are crucial for reproductive female fertility [4–7]. Reduced ability to maintain metaphase II success. Another key aspect of this meiotic arrest and exit is arrest is also observed in eggs with down-regulated activity of regulation of the metaphase II spindle, which must be appropriately localized adjacent to the egg cortex during endogenous meiotic inhibitor 2 (EMI2), CDC25A, or PP2A, Downloaded from www.biolreprod.org. metaphase II and then progress into successful asymmetric with reduced levels of cytosolic zinc, or undergoing postovu- cytokinesis to produce the second polar body.
    [Show full text]
  • University of Napoli Federico Ii
    UNIVERSITY OF NAPOLI FEDERICO II Doctorate School in Molecular Medicine Doctorate Program in Genetics and Molecular Medicine Coordinator: Prof. Lucio Nitsch XXVII Cycle “REGULATION OF p14ARF TUMOR SUPPRESSOR ACTIVITIES AND FUNCTIONS” MICHELA RANIERI Napoli 2015 REGULATION OF p14ARF TUMOR SUPPRESSOR ACTIVITIES AND FUNCTIONS 2 TABLE OF CONTENTS 1. BACKGROUND 6 1.1 THE HUMAN INK4/ARF LOCUS ENCODES p14ARF PROTEIN. 8 1.2 THE ONCOSUPPRESSIVE ROLE OF p14ARF PROTEIN. 11 1.3 ARF AS AN ONCOGENE: A NEW ROLE. 17 1.4 OTHER FUNCTIONS OF ARF PROTEIN. 20 1.5 ARF TURNOVER. 23 2. PRELIMINARY DATA AND AIM OF THE STUDY. 27 3. MATERIALS AND METHODS. 28 4. RESULTS. 32 4.1 Mutation of Threonine 8 does not affect ARF folding. 32 4.2 Mutation of Threonine 8 affects ARF protein turn-over. 35 4.3 Mimicking ARF phosphorylation inhibits ARF biological activity. 37 4.4 Mimicking Threonine 8 phosphorylation induces ARF accumulation in the cytoplasm and nucleus. 39 4.5 Cytoplasmic localized ARF protein is phosphorylated. 41 4.6 ARF loss blocks cell proliferation in both Hela and HaCat cells. 43 4.7 ARF loss determines a round phenotype of the cells. 46 4.8 Round phenotype is not apoptosis-dependent. 49 4.9 ARF loss induces DAP Kinase-dependent apoptosis. 51 5. DISCUSSION. 54 6. CONCLUSIONS. 63 7. REFERENCES. 64 3 LIST OF PUBLICATIONS RELATED TO THE THESIS. Vivo M, Ranieri M, Sansone F, Santoriello C, Calogero RA, Calabrò V, Pollice A, La Mantia G. “Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation”. PLoSONE8(1):e53631.
    [Show full text]
  • Interaction of Cdc2 and Rum1 Regulates Start and S-Phase in Fission Yeast
    Journal of Cell Science 108, 3285-3294 (1995) 3285 Printed in Great Britain © The Company of Biologists Limited 1995 JCS8905 Interaction of cdc2 and rum1 regulates Start and S-phase in fission yeast Karim Labib1,2,3, Sergio Moreno3 and Paul Nurse1,2,* 1ICRF Cell Cycle Laboratory, Department of Biochemistry, University of Oxford, Oxford, OX1 1QU, UK 2ICRF, PO Box 123, Lincolns Inn Fields, London WC2A 3PX, UK 3Instituto de Microbiologia-Bioquimica, CSIC/Universidad de Salamanca, Edificio Departamental, Campus Miguel de Unamuno, 37007 Salamanca, Spain *Author for correspondence SUMMARY The p34cdc2 kinase is essential for progression past Start in rum1, can disrupt the dependency of S-phase upon mitosis, the G1 phase of the fission yeast cell cycle, and also acts in resulting in an extra round of S-phase in the absence of G2 to promote mitotic entry. Whilst very little is known mitosis. We show that cdc2 and rum1 interact in this about the G1 function of cdc2, the rum1 gene has recently process, and describe dominant cdc2 mutants causing been shown to encode an important regulator of Start in multiple rounds of S-phase in the absence of mitosis. We fission yeast, and a model for rum1 function suggests that suggest that interaction of rum1 and cdc2 regulates Start, it inhibits p34cdc2 activity. Here we present genetic data and this interaction is important for the regulation of S- cdc2 suggesting that rum1 maintains p34 in a pre-Start G1 phase within the cell cycle. form, inhibiting its activity until the cell achieves the critical mass required for Start, and find that in the absence of rum1 p34cdc2 has increased Start activity in vivo.
    [Show full text]
  • Immortalization of Primary Human Prostate Epithelial Cells by C-Myc
    Research Article Immortalization of Primary Human Prostate Epithelial Cells by c-Myc Jesu´s Gil,1 Preeti Kerai,3 Matilde Lleonart,4 David Bernard,5 Juan Cruz Cigudosa,6 Gordon Peters,1 Amancio Carnero,7 and David Beach2 1Molecular Oncology Laboratory, Cancer Research UK, London Research Institute; 2Center for Cutaneous Biology, Institute for Cell and Molecular Sciences, London, United Kingdom; 3University of Cambridge, Cancer Research UK, Department of Oncology and the Medical Research Council Cancer Cell Unit, Hutchinson/Medical Research Council Research Centre, Cambridge, United Kingdom; 4Department of Pathology, Hospital Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain; 5Free University of Brussels, Laboratory of Molecular Virology, Faculty of Medicine, Brussels, Belgium; and 6Cytogenetics Unit, Biotechnology Program and 7Experimental Therapeutics Program, Centro Nacional de Investigaciones Oncolo´gicas, Madrid, Spain Abstract keratinocytes grown on feeder layers could be immortalized by hTERT alone, others have found a requirement for inactivation of A significant percentage of prostate tumors have amplifica- INK4a tions of the c-Myc gene, but the precise role of c-Myc in the Rb/p16 pathway even in these conditions (9). prostate cancer is not fully understood. Immortalization of The establishment of improved models of human cancer human epithelial cells involves both inactivation of the Rb/ progression relies on the expression of defined combinations of p16INK4a pathway and telomere maintenance, and it has been genes that mirror those naturally arising in cancer. In this context, recapitulated in culture by expression of the catalytic subunit significant advances have been achieved recently (10–13). Transfor- of telomerase, hTERT, in combination with viral oncoproteins.
    [Show full text]
  • Increase in Fru-2,6-P2 Levels Results in Altered Cell Division In
    Available online at www.sciencedirect.com Biochimica et Biophysica Acta 1783 (2008) 144–152 www.elsevier.com/locate/bbamcr Increase in Fru-2,6-P2 levels results in altered cell division in Schizosaccharomyces pombe ⁎ ⁎ Silvia Fernández de Mattos a,c, , Vicenç Alemany b, Rosa Aligué b, Albert Tauler c, a Cancer Cell Biology and Translational Oncology Group, Institut Universitari d’Investigació en Ciències de la Salut (IUNICS), Departament de Biologia Fonamental, Universitat de les Illes Balears, Crta Valldemossa km 7.5, E-07122 Palma, Illes Balears, Spain b Departament de Biologia Cellular, Institut de Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, E-08036 Barcelona, Catalunya, Spain c Departament de Bioquímica i Biologia Molecular-Divisió IV, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal 643, E-08028 Barcelona, Catalunya, Spain Received 25 May 2007; received in revised form 17 July 2007; accepted 18 July 2007 Available online 24 July 2007 Abstract Mitogenic response to growth factors is concomitant with the modulation they exert on the levels of Fructose 2,6-bisphosphate (Fru-2,6-P2), an essential activator of the glycolytic flux. In mammalian cells, decreased Fru-2,6-P2 concentration causes cell cycle delay, whereas high levels of Fru- 2,6-P2 sensitize cells to apoptosis. In order to analyze the cell cycle consequences due to changes in Fru-2,6-P2 levels, the bisphosphatase-dead mutant (H258A) of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase enzyme was over-expressed in Schizosaccharomyces pombe cells and the variation in cell phenotype was studied. The results obtained demonstrate that the increase in Fru-2,6-P2 levels results in a defective division of S.
    [Show full text]
  • Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate
    Published OnlineFirst March 6, 2019; DOI: 10.1158/0008-5472.CAN-18-1421 Cancer Metabolism and Chemical Biology Research Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem–Like Cells In Vivo Dongyuan Wang1, Wenjun Li1, Rongtong Zhao1, Longjian Chen1, Na Liu1, Yuan Tian2, Hui Zhao3, Mingsheng Xie1, Fei Lu1, Qi Fang1, Wei Liang4, Feng Yin1, and Zigang Li1 Abstract FDA-approved HDAC inhibitors exhibit dose- A DNA H3K56 H3K64 H3K79 H3K115 limiting adverse effects; thus, we sought to improve Histone 3 αN α1 α2 α3 +H N the therapeutic windows for this class of drugs. In 3 L1 L2 this report, we describe a new class of peptide- Histone tail H3K56 Cap + based HDAC inhibitors derived from the Zn2 TD: Helix stabilization linker HDAC1-specific substrate H3K56 with improved Zinc binding O NH R nonspecific toxicity compared with traditional Histone H N CH small-molecular inhibitors. We showed that our 3 O designed peptides exerted superior antiprolifera- HDACs O HN tion effects on cancer stem–like cells with minimal Acetylated OH lysine such as H3K56Ac Helix stability HDACs N-terminus for modification toxicity to normal cells compared with the small- Facile construction molecular inhibitor SAHA, which showed nonspe- HDACs inactivation in vitro and in vivo O NH O R R NH fi B NH NH ci c toxicity to normal and cancer cells. These O O O O R HN R HN peptide inhibitors also inactivated cellular HDAC1 OH OH and HDAC6 and disrupted the formation of the HDAC1, LSD1, and CoREST complex.
    [Show full text]
  • P53 Isoforms and Their Implications in Cancer
    cancers Review p53 Isoforms and Their Implications in Cancer Maximilian Vieler and Suparna Sanyal * ID Department of Cell and Molecular Biology, Uppsala University, Box-596, BMC, Uppsala SE-75124, Sweden; [email protected] * Correspondence: [email protected] Received: 22 July 2018; Accepted: 18 August 2018; Published: 25 August 2018 Abstract: In this review we focus on the major isoforms of the tumor-suppressor protein p53, dysfunction of which often leads to cancer. Mutations of the TP53 gene, particularly in the DNA binding domain, have been regarded as the main cause for p53 inactivation. However, recent reports demonstrating abundance of p53 isoforms, especially the N-terminally truncated ones, in the cancerous tissues suggest their involvement in carcinogenesis. These isoforms are D40p53, D133p53, and D160p53 (the names indicate their respective N-terminal truncation). Due to the lack of structural and functional characterizations the modes of action of the p53 isoforms are still unclear. Owing to the deletions in the functional domains, these isoforms can either be defective in DNA binding or more susceptive to altered ‘responsive elements’ than p53. Furthermore, they may exert a ‘dominant negative effect’ or induce more aggressive cancer by the ‘gain of function’. One possible mechanism of p53 inactivation can be through tetramerization with the D133p53 and D160p53 isoforms—both lacking part of the DNA binding domain. A recent report and unpublished data from our laboratory also suggest that these isoforms may inactivate p53 by fast aggregation—possibly due to ectopic overexpression. We further discuss the evolutionary significance of the p53 isoforms. Keywords: p53; cancer; p53 isoform; D133p53; D160p53; D40p53; aggregation; prion 1.
    [Show full text]
  • Utility of DNA Methylation Markers for Diagnosing Cancer
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector International Journal of Surgery 8 (2010) 194–198 Contents lists available at ScienceDirect International Journal of Surgery journal homepage: www.theijs.com Review Utility of DNA methylation markers for diagnosing cancer Sohail A. Qureshi a,*, Muhammed Umair Bashir b, Ahmed Yaqinuddin c a Department of Biological and Biomedical Sciences, and Medical College, The Aga Khan University, Stadium Road, Karachi 74800, Pakistan b Medical College, The Aga Khan University, Stadium Road, Karachi 74800, Pakistan c Medical College, Al-Faisal University, Riyadh, Saudi Arabia article info abstract Article history: DNA methylation occurs at the CpG residues and serves as a powerful epigenetic mechanism that Received 29 September 2009 negatively regulates gene expression. This process is catalyzed by DNA methyltransferases and occurs Received in revised form within ‘‘CpG islands’’ found in the promoter regions of >70% of human genes. Given the important role of 21 January 2010 DNA methylation in regulating gene expression, un-programmed changes in methylation patterns are Accepted 2 February 2010 expected to either silence or activate transcription of tumor suppressor genes (via hypermethylation) or Available online 6 February 2010 oncogenes (via demethylation), respectively, and by doing so promote a disease state. In light of the fact that a number of different cancers are frequently associated with hypermethylated tumor suppressor Keywords: DNA methylation genes together with the observation that tumor derived genomic DNAs are present in various body fluids Cancer including serum/plasma, urine, sputum and bronchial lavage, methylated DNA has shown tremendous Biomarker promise to serve as a robust biomarker for detecting cancer.
    [Show full text]
  • Defining the Functions of a Conserved Hydrophobic Domain in the ARF Tumor Suppressor
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2013 Defining the functions of a conserved hydrophobic domain in the ARF tumor suppressor Aymen Hariz Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd © The Author Downloaded from https://scholarscompass.vcu.edu/etd/481 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. © Aymen Faris Hariz 2013 DEFINING THE FUNCTIONS OF A CONSERVED HYDROPHOBIC DOMAIN IN THE ARF TUMOR SUPPRESSOR A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University By Aymen Faris Hariz, B.Sc. Lebanese University, 2004 Director: Steven R. Grossman, MD, PhD Professor Department of Hematology, Oncology and Palliative Care Virginia Commonwealth University Richmond, Virginia April, 2013 ii ACKNOWLEDGEMENTS I would like to express my sincere gratitude to all the people who helped me with resources and guidance throughout this study. I am grateful to my thesis advisor Dr. Steven Grossman for giving me this opportunity and supporting me in my quest to fulfill my research work under his supervision. I am indebted to Dr. Grossman for his time, extensive knowledge, patience and most of all for his care and advice. I am also thankful to the jury for their participation and invaluable suggestions. I am especially appreciative to all the efforts and contributions that former and current members of the Grossman lab have provided me, in particular Dr.
    [Show full text]
  • Characterisation of Two Class V Myosins in the Fission Yeast Schizosaccharomyces Pombe
    Characterisation of Two Class V Myosins in the Fission Yeast Schizosaccharomyces pombe Them Zaw Win A Thesis Submitted to the University of London for the Degree of Doctor of Philosophy October 2000 Department of Biology University College London Gower Street London WCIE 6BT ProQuest Number: U643836 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest U643836 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 for mum and dad Acknowledgements First and foremost I would like to thank the most important person in my research study my supervisor. Prof. Jerry Hyams. I am indebted to Jerry for his guidance, support, fairness and encouragement throughout this project. The one thing I would like to thank him most for, is his faith in me for which my heart felt and deepest gratitude goes out to Jerry and for which I will always remember. I would also like to thank Dr Yannick Gachet for encouraging me to carry out important experiments and in particular teaching me how to do them. My thanks to Dr Daniel Mulvihill for teaching me how to perform certain experiments efficiently so that results can be obtained quickly.
    [Show full text]
  • Collaboration of G 1 Cyclins in the Functional Inactivation of the Retinoblastoma Protein
    Downloaded from genesdev.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press Collaboration of G 1 cyclins in the functional inactivation of the retinoblastoma protein Masanori Hatakeyama, Julie A. Brill, 1 Gerald R. Fink, and Robert A. Weinberg The Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142 USA The retinoblastoma gene product (pRB) constrains cell proliferation by preventing cell-cycle progression from the G~ to S phase. Its growth-inhibitory effects appear to be reversed by hyperphosphorylation occurring during Gx. This process is thought to involve GI cyclins and cyclin-dependent kinases (cdks). Here we report that the cell cycle-dependent phosphorylation of mammalian pRB is faithfully reproduced when it is expressed in Saccharomyces cerevisiae. As is the case in mammalian cells, this phosphorylation requires an intact oncoprotein-binding domain and is inhibited by a negative growth factor, in this case a mating pheromone. Expression of pRB in cln (-) mutants indicates that specific combinations of endogenous G~ cyclins, Cln3 and either Clnl or Cln2 are required for pRB hyperphosphorylation in yeast. Moreover, expression of mammalian G 1 cyclins in cln (-) yeast cells indicates that the functions of Cln2 and Cln3 in pRB hyperphosphorylation can be complemented by human cyclin E and cyclin D1, respectively. These observations suggest a functional heterogeneity among G~ cyclin-cdk complexes and indicate a need for the involvement of multiple G~ cyclins in promoting pRB hyperphosphorylation and resulting cell-cycle progression. [Key Words: Cell-cycle; G~ cyclins; cyclin-dependent kinases; Saccharomyces cerevisiae; retinoblastoma protein; phosphorylation] Received March 11, 1994; revised version accepted June 21, 1994.
    [Show full text]